Recent News & Research

J&J buys novel lung cancer drug from South Korea’s Yuhan ResearchTreatments

J&J buys novel lung cancer drug from South Korea’s Yuhan

*November 7, 2018* Janssen Biotech has bought Yuhan’s Lazertinib, a novel clinical-stage therapeutic candidate for the treatment of patients with non-small cell lung cancer (NSCLC). J&J’s pharma arm, Janssen, struck the deal with South Korea-based Yuhan and has agreed to pay $50m upfront to secure the licence. The move sent…
laurabbook@gmail.com
November 22, 2018
Bring Hope Home Research

Bring Hope Home

June 19th Living Room "Resistance to Targeted Therapy" Dr. Colin Blakely will be discussing all the questions about progression in your lung cancer and where to go and what to do. Dr. Blakely will be talking about what is happening in the research field from next generation therapies after progression from your 2nd…
cece
June 18, 2018
A Mix-and-Match Approach to Treating Non-Small-Cell Lung Cancer ResearchStories

A Mix-and-Match Approach to Treating Non-Small-Cell Lung Cancer

https://egfrcancer.org/wp-content/uploads/2018/03/Teri-Kennedy.jpg *** This article was first posted on www.curetoday.com*** During summer 2015, Teri Kennedy was at a yoga festival in Squaw Valley, California, when she started to wheeze and had trouble breathing. The inhaler her doctor gave her didn’t help. When the then 51-year-old from Sacramento returned home, she went…
cece
May 1, 2018